Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 61 to 70 of 1535

TitleReference numberPublishedLast updated
Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosisTA127
Alemtuzumab for treating highly active relapsing–remitting multiple sclerosisTA312
Cladribine for treating relapsing–remitting multiple sclerosisTA616
Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusionTA283
Ranibizumab and pegaptanib for the treatment of age-related macular degenerationTA155
Ranibizumab for treating choroidal neovascularisation associated with pathological myopiaTA298
Selective internal radiation therapy for neuroendocrine tumours that have metastasised to the liverIPG786
Endoscopic duodenal mucosal resurfacing for insulin resistance in type 2 diabetesIPG787
Image-guided percutaneous laser ablation for primary and secondary liver tumoursIPG788
Atogepant for preventing migraineTA973

Results per page

  1. 10
  2. 25
  3. 50
  4. All